Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | CTSK | P43235 | 4/20 | 0.34 |
| ▸ | CTSS | P25774 | 2/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CTSL | P07711 | 1/20 | 0.30 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.30 |
| ▸ | DPP4 | P27487 | 1/20 | 0.30 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.30 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.30 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7544155 | 0.96 | ALDH1A1 (0.39) | ALDH1A1TSHRCTSKCTSSCA1 | |
| SCHEMBL7541408 | 0.94 | ALDH1A1 (0.38) | ALDH1A1TSHRPLA2G2C | |
| SCHEMBL7542057 | 0.94 | ALDH1A1 (0.38) | ALDH1A1TSHRPLA2G2C | |
| SCHEMBL7548739 | 0.94 | ALDH1A1 (0.38) | ALDH1A1TSHRPLA2G2C | |
| SCHEMBL7544981 | 0.94 | ALDH1A1 (0.38) | ALDH1A1TSHRPLA2G2C | |
| SCHEMBL7545523 | 0.91 | ALDH1A1 (0.46) | ALDH1A1TSHRCTSKCTSS | |
| SCHEMBL7545854 | 0.90 | ALDH1A1 (0.36) | ALDH1A1TSHRCTSKCTSSCA1 | |
| SCHEMBL7542574 | 0.90 | ALDH1A1 (0.36) | ALDH1A1TSHRCTSKCTSSCA1 | |
| SCHEMBL7547834 | 0.86 | TSHR (0.35) | ALDH1A1TSHRCTSKCTSSPLA2G2C | |
| SCHEMBL7547882 | 0.86 | TSHR (0.35) | ALDH1A1TSHRCTSKCTSSPLA2G2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020065314-A1 | COMPOSITIONS AND METHOD FOR STIMULATING HAIR GROWTH | S.N. BIOTECH, INC. | 2002-05-30 | — | — | US | claimed |
| US-20020065314-A1 | COMPOSITIONS AND METHOD FOR STIMULATING HAIR GROWTH | S.N. BIOTECH, INC. | 2002-05-30 | — | — | US | disclosed |
| EP-0824316-A4 | COMPOSITIONS AND METHODS FOR STIMULATING HAIR GROWTH | NIELSEN THOR B (US) | 2001-01-17 | — | — | EP | disclosed |
| US-5767152-A | USING A CYANOCARBOXYLIC ACID | S.N. BIOTECH, INC. | 1998-06-16 | — | — | US | disclosed |
| EP-0824316-A1 | COMPOSITIONS AND METHODS FOR STIMULATING HAIR GROWTH | Nielsen, Thor, B. (US) | 1998-02-25 | — | — | EP | disclosed |
| WO-1996034526-A1 | COMPOSITIONS AND METHODS FOR STIMULATING HAIR GROWTH | NIELSEN THOR B (US) | 1996-11-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020065314-A1 | COMPOSITIONS AND METHOD FOR STIMULATING HAIR GROWTH | AREG, NGF, HDGF | ALDH1A1 3677/4885TSHR 148/4885CTSK 2181/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.